SCHEMBL5367282

SCHEMBL5367282

Cc1ccc(C=C2C(=O)Nc3ccc(CCCl)cc32)o1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.60
ALDH1A1 P00352 5/20 0.60
MEN1 O00255 4/20 0.60
POLB P06746 3/20 0.60
LMNA P02545 2/20 0.60
THRB P10828 2/20 0.60
ALOX12 P18054 2/20 0.60
DYRK1A Q13627 1/20 0.60
RET P07949 3/20 0.47
MAPT P10636 5/20 0.47
HPGD P15428 2/20 0.47
GPR55 Q9Y2T6 2/20 0.47
PKM P14618 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
NPSR1 Q6W5P4 1/20 0.47
PTPN1 P18031 6/20 0.45
PTPN2 P17706 1/20 0.43
RPS6KA3 P51812 1/20 0.43
MAPK1 P28482 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5363472 0.86 PTPN1 (0.48) KMT2AALDH1A1MEN1POLBLMNA
SCHEMBL5369248 0.86 RET (0.65) KMT2AALDH1A1MEN1POLBLMNA
SCHEMBL5366390 0.85 ALDH1A1 (0.45) KMT2AALDH1A1MEN1POLBLMNA
SCHEMBL7134047 0.84 PTPN1 (0.48) KMT2AALDH1A1MEN1POLBLMNA
SCHEMBL5357851 0.82 RET (0.53) KMT2AALDH1A1MEN1POLBLMNA
SCHEMBL7137564 0.80 PSEN1 (0.52) KMT2AMEN1RETMAPT
SCHEMBL6830071 0.79 MEN1 (0.67) KMT2AALDH1A1MEN1POLBLMNA
SCHEMBL6854443 0.79 MEN1 (0.67) KMT2AALDH1A1MEN1POLBLMNA
SCHEMBL5367384 0.79 RPS6KA3 (0.43) KMT2AALDH1A1MEN1POLBLMNA
SCHEMBL5370564 0.78 PDPK1 (0.47) POLBLMNADYRK1ARETMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK KMT2A 4060/4885ALDH1A1 2044/4885MEN1 3855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.